Devices, Pharmaceuticals, and Environmental Products

There has been much debate about the risk of infection to patients from contaminated health care surfaces. It is now recognized that the environment can facilitate the transmission of several important nosocomial pathogens, including resistant enterococci (VRE), Clostridium difficile, Acinetobacter spp., Methicillin-resistant Staphylococcus aureus (MRSA) and Norovirus. These pathogens are frequently paid by patients and staff, after which they contaminate surfaces for days and increase the risk of acquisition for other patients. Environmental screening confirms the repeated contamination of supplies, equipment and general sites in bed spaces and the rooms of patients colonized or infected and often through multiple clinical areas in a health care facility. The hands of health care workers are likely to touch these contaminated surfaces during patient care, increasing the risk of transmission to others. 

  • Environmental factors
  • Infection Hazards from Microbial Contamination of Pharmaceuticals
  • Type Of Organism
  • Infective Dose
  • Host Resistance to Infection
  • Route of Administration
  • Contamination of Medical Devices
  • Microbial Spoilage of Pharmaceutical Products
  • Factors that affect the Survival and Growth of Products
  • Sources of Microbial Contamination In Pharmaceutical Products
  • Biopharmaceutical products

Related Conference of Devices, Pharmaceuticals, and Environmental Products

Devices, Pharmaceuticals, and Environmental Products Conference Speakers